Acibadem City Clinic Tokuda Hospital is the largest medical facility in Bulgaria, built and developed with private investments. It was opened in 2006 as part of a Japanese medical group, owned by the physician and entrepreneur Dr. Torao Tokuda.

During the past decade, Acibadem City Clinic Tokuda Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 12 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Acibadem City Clinic Tokuda Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Celgene" with 5 trials sponsored, "Incyte Corporation" with 3 trials sponsored, "Assembly Biosciences" with 2 trials sponsored and "Biolex Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Acibadem City Clinic Tokuda Hospital" #1 collaborator was "Arbutus Biopharma Corporation" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Acibadem City Clinic Tokuda Hospital" are "Multiple Sclerosis" (4 trials), "Crohn Disease" (3 trials), "Body Indication" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Chronic Hepatitis B" (2 trials). Many other conditions were trialed in "Acibadem City Clinic Tokuda Hospital" in a lesser frequency.

Most popular intervention types in "Acibadem City Clinic Tokuda Hospital" are "Drug" (36 trials), "Other" (5 trials), "Biological" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Ozanimod" (5 trials), "Carboplatin" (2 trials), "Docetaxel" (2 trials) and "IVA337" (2 trials). Other intervention names were less common.

The vast majority of trials in "Acibadem City Clinic Tokuda Hospital" are 42 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Acibadem City Clinic Tokuda Hospital". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Acibadem City Clinic Tokuda Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Acibadem City Clinic Tokuda Hospital, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".